A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu(88-102)

PURPOSE: Over the past two decades, there has been significant interest in targeting HER-2/neu in immune-based approaches for the treatment of HER-2/neu+ cancers. For example, peptide vaccination using a CD8 T cell activating HER-2/neu epitope (amino acids 369-377) is an approach that is being consi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Karyampudi, Lavakumar, Formicola, Courtney, Erskine, Courtney L., Maurer, Matthew J., Ingle, James N., Krco, Christopher J., Wettstein, Peter J., Kalli, Kimberly R., Fikes, John D., Beebe, Melanie, Hartmann, Lynn C., Disis, Mary L., Ferrone, Soldano, Ishioka, Glenn, Knutson, Keith L.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2818599/
https://ncbi.nlm.nih.gov/pubmed/20103660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-2781
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares